Gene: MSTO1
Official Full Name: misato mitochondrial distribution and morphology regulator 1provided by HGNC
Gene Summary: Involved in mitochondrion distribution; mitochondrion organization; and positive regulation of mitochondrial fusion. Located in mitochondrial outer membrane. Is active in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15997 | MSTO1 Knockout cell line (HeLa) | Human | MSTO1 | 1:3~1:6 | Negative | Online Inquiry |
KO15998 | MSTO1 Knockout cell line (HCT 116) | Human | MSTO1 | 1:2~1:4 | Negative | Online Inquiry |
KO15999 | MSTO1 Knockout cell line (HEK293) | Human | MSTO1 | 1:3~1:6 | Negative | Online Inquiry |
KO16000 | MSTO1 Knockout cell line (A549) | Human | MSTO1 | 1:3~1:4 | Negative | Online Inquiry |
MSTO1 Gene Knockout Cell Lines represent a pivotal advancement in the study of mitochondrial biology and cellular metabolism. The MSTO1 gene is known to play a critical role in mitochondrial dynamics, influencing processes such as mitochondrial fission and fusion, which are essential for maintaining cellular energy homeostasis and viability. By employing CRISPR-Cas9 technology, these cell lines are meticulously engineered to exhibit a complete knockout of the MSTO1 gene, allowing researchers to investigate the functional repercussions of its absence on cellular physiology.
The primary function of these knockout cell lines is to facilitate in-depth analyses of mitochondrial biogenesis, susceptibility to apoptosis, and the role of MSTO1 in various stress responses. This is crucial for understanding mitochondrial-related disorders, metabolic syndromes, and potential therapeutic interventions. By providing a precise model for studying the loss of MSTO1, these cell lines enable researchers to elucidate the gene's biological pathways and interactions, thereby contributing to the discovery of novel biomarkers and targeted therapies.
In research and clinical settings, MSTO1 Gene Knockout Cell Lines offer significant advantages over traditional models. They allow for reproducible studies of dysregulated mitochondrial function and associated pathologies without the confounding effects of a wild-type genetic background. Moreover, the knockout cell lines can be employed in drug screening assays, providing insights into how MSTO1 modulation affects therapeutic outcomes.
The value of MSTO1 Gene Knockout Cell Lines extends beyond basic research; they are instrumental for pharmaceutical companies and academic institutions focused on developing targeted therapies for diseases linked to mitochondrial dysfunction, thereby enhancing research efficacy and translational applications.
Our company is committed to delivering high-quality biological products that empower researchers and clinicians alike. With extensive expertise in genetic engineering and a focus on precision applications, we are dedicated to supporting cutting-edge research that drives innovation in the life sciences sector.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.